DK0813870T3 - Anvendelse af darifenacin til at forstærke kognitive funktioner - Google Patents
Anvendelse af darifenacin til at forstærke kognitive funktionerInfo
- Publication number
- DK0813870T3 DK0813870T3 DK97303879T DK97303879T DK0813870T3 DK 0813870 T3 DK0813870 T3 DK 0813870T3 DK 97303879 T DK97303879 T DK 97303879T DK 97303879 T DK97303879 T DK 97303879T DK 0813870 T3 DK0813870 T3 DK 0813870T3
- Authority
- DK
- Denmark
- Prior art keywords
- darifenacin
- cognitive functions
- enhance cognitive
- treatment
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/01—Carboxylic ester hydrolases (3.1.1)
- C12Y301/01007—Acetylcholinesterase (3.1.1.7)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9612710.5A GB9612710D0 (en) | 1996-06-18 | 1996-06-18 | Method of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0813870T3 true DK0813870T3 (da) | 2003-08-18 |
Family
ID=10795468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97303879T DK0813870T3 (da) | 1996-06-18 | 1997-06-05 | Anvendelse af darifenacin til at forstærke kognitive funktioner |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5837724A (da) |
| EP (1) | EP0813870B1 (da) |
| JP (1) | JP3453493B2 (da) |
| KR (1) | KR980000445A (da) |
| AT (1) | ATE243514T1 (da) |
| AU (1) | AU2495697A (da) |
| CA (1) | CA2208111C (da) |
| DE (1) | DE69722999T2 (da) |
| DK (1) | DK0813870T3 (da) |
| ES (1) | ES2197972T3 (da) |
| GB (1) | GB9612710D0 (da) |
| HU (1) | HUP9701060A3 (da) |
| IL (1) | IL121036A0 (da) |
| PT (1) | PT813870E (da) |
| ZA (1) | ZA975311B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19707655A1 (de) * | 1997-02-26 | 1998-08-27 | Hoechst Ag | Kombinationspräparat zur Anwendung bei Demenz |
| US20040209849A1 (en) * | 1998-11-27 | 2004-10-21 | Sanochemia Pharmazeutika Aktiengesellschaft | Use of effectors of the central cholinergic nervous system for treatment of delirium |
| GB0207104D0 (en) * | 2002-03-26 | 2002-05-08 | Pfizer Ltd | Stable hydrate of a muscarinic receptor antagonist |
| EP1615881A2 (en) * | 2003-04-01 | 2006-01-18 | Theravance, Inc. | Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| CA2718411C (en) | 2008-03-27 | 2016-02-16 | Chase Pharmaceuticals Corporation | Use and composition for treating dementia |
| US10265311B2 (en) | 2009-07-22 | 2019-04-23 | PureTech Health LLC | Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation |
| HUE044653T2 (hu) | 2009-07-22 | 2019-11-28 | PureTech Health LLC | Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk |
| CA3060030A1 (en) * | 2017-06-01 | 2018-12-06 | Eisai R&D Management Co., Ltd. | Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil |
| CA3180743A1 (en) | 2018-09-28 | 2020-04-02 | Karuna Therapeutics, Inc. | Composition comprising xanomeline and trospium for treating disorders ameliorated by muscarinic receptor activation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5233053A (en) * | 1989-03-17 | 1993-08-03 | Pfizer Inc. | Pyrrolidine derivatives |
| GB9400600D0 (en) * | 1994-01-14 | 1994-03-09 | Pfizer Ltd | Treatment of motion seckness |
-
1996
- 1996-06-18 GB GBGB9612710.5A patent/GB9612710D0/en active Pending
-
1997
- 1997-06-05 EP EP97303879A patent/EP0813870B1/en not_active Expired - Lifetime
- 1997-06-05 DE DE69722999T patent/DE69722999T2/de not_active Expired - Lifetime
- 1997-06-05 AT AT97303879T patent/ATE243514T1/de active
- 1997-06-05 DK DK97303879T patent/DK0813870T3/da active
- 1997-06-05 ES ES97303879T patent/ES2197972T3/es not_active Expired - Lifetime
- 1997-06-05 PT PT97303879T patent/PT813870E/pt unknown
- 1997-06-09 IL IL12103697A patent/IL121036A0/xx unknown
- 1997-06-10 JP JP15189997A patent/JP3453493B2/ja not_active Expired - Lifetime
- 1997-06-11 US US08/872,891 patent/US5837724A/en not_active Expired - Lifetime
- 1997-06-16 CA CA002208111A patent/CA2208111C/en not_active Expired - Lifetime
- 1997-06-17 KR KR1019970025073A patent/KR980000445A/ko not_active Application Discontinuation
- 1997-06-17 ZA ZA975311A patent/ZA975311B/xx unknown
- 1997-06-17 AU AU24956/97A patent/AU2495697A/en not_active Abandoned
- 1997-06-17 HU HU9701060A patent/HUP9701060A3/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0813870A1 (en) | 1997-12-29 |
| ZA975311B (en) | 1998-12-17 |
| HU9701060D0 (en) | 1997-08-28 |
| HUP9701060A2 (hu) | 1998-12-28 |
| DE69722999D1 (de) | 2003-07-31 |
| DE69722999T2 (de) | 2003-12-18 |
| JPH1059848A (ja) | 1998-03-03 |
| GB9612710D0 (en) | 1996-08-21 |
| HUP9701060A3 (en) | 1999-03-29 |
| KR980000445A (ko) | 1998-03-30 |
| US5837724A (en) | 1998-11-17 |
| PT813870E (pt) | 2003-10-31 |
| EP0813870B1 (en) | 2003-06-25 |
| ES2197972T3 (es) | 2004-01-16 |
| IL121036A0 (en) | 1997-11-20 |
| JP3453493B2 (ja) | 2003-10-06 |
| AU2495697A (en) | 1998-01-08 |
| ATE243514T1 (de) | 2003-07-15 |
| CA2208111C (en) | 2002-10-15 |
| CA2208111A1 (en) | 1997-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT936908E (pt) | Derivados anticonvulsivos uteis no tratamento de esclerose lateral amiotrofica (ela) | |
| DE69721254T8 (de) | Gesichtsmaske mit Universalanpassung | |
| DE69730043D1 (de) | Implantierbare eletrodenleitung | |
| LV12579B (lv) | Veja energetiska iekarta un energijas parveidosanas panemiens | |
| PT901487E (pt) | 4(3h)-quinazolinonas 2,3,6-trissubstituidas | |
| DK0799819T3 (da) | 1-Dimethylaminomethyl-2-phenylcycloalk-2-enforbindelser med analgesisk virkning | |
| ID20531A (id) | Alat pengobatan | |
| DE69733470D1 (de) | Laserbearbeitung | |
| DK0813870T3 (da) | Anvendelse af darifenacin til at forstærke kognitive funktioner | |
| DE29609021U1 (de) | Schutzbrille | |
| TR199501714A1 (tr) | Bosluklar iceren sogurucu cisim. | |
| DE59702263D1 (de) | Reinigung von p.p-Bisphenolat-Lösungen | |
| DK1052991T3 (da) | Topisk anvendelse af loperamid til behandling af mikrobielle infektioner | |
| DE29613426U1 (de) | Schutzbrille | |
| DE9319114U1 (de) | Ohrclip mit austauschbarer Abdeckung, speziell Hörgerät in Form eines Ohrclip | |
| IT233164Y1 (it) | Brandina o cuccia pieghegole e/o smontabile. | |
| DK0661058T3 (da) | Anvendelse af bradykininantagonister til behandling af virussygdomme | |
| FR2709944B1 (fr) | Agrafe chirurgicale. | |
| NL1000434C2 (nl) | Acetyleencopolymeren en membranen daarvan. | |
| ES1028150Y (es) | Pieza de lastre utilizada en cinturones de actividades subacuaticas. | |
| ES1033996Y (es) | Maquina trituradora-seleccionadora de gravas y similares. | |
| KR970050684U (ko) | 졸음방지용 모자 | |
| KR900007413A (ko) | 에이즈 발병방지, 치료제 및 그 치료용 조성물 | |
| DE29606283U1 (de) | Schlüssel, Schlüsselkopf und Schlüsselrohling | |
| FI962173A0 (fi) | Med bladskydd foersedd saogstaellning |